International Journal of Preventive Medicine

ORIGINAL ARTICLE
Year
: 2016  |  Volume : 7  |  Issue : 1  |  Page : 117-

The effects of nanoparticles containing iron on blood and inflammatory markers in comparison to ferrous sulfate in anemic rats


Elaheh Honarkar Shafie1, Seyed Ali Keshavarz1, Mohammad Esmaiel Kefayati2, Fatemeh Taheri3, Parvin Sarbakhsh4, Mohammad Reza Vafa5 
1 Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran
2 Department of Applied Chemistry, Faculty of Chemistry, Amirkabir University of Technology, Tehran, Iran
3 Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
4 Department of Statistic and Epidemiology, Faculty of Nutrition and Health, Tabriz University of Medical Sciences, Tabriz, Iran
5 Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

Correspondence Address:
Mohammad Reza Vafa
School of Public Health, Iran University of Medical Sciences, Hemmat Highway, Tehran
Iran

Background: Ferrous sulfate is the most used supplement for treating anemia, but it can result in unfavorable side effects. Nowadays, nanotechnology is used as a way to increase bioavailability and decrease the side effects of drugs and nutrients. This study investigates the effects of nanoparticles containing iron on blood and inflammatory markers in comparison to ferrous sulfate in anemic rats. Methods: To induce the model of hemolytic anemia, 50 mg/kg bw phenylhydrazine was injected intraperitoneally in rats on the 1 st day and 25 mg/kg bw for the four following days. Then, rats were randomly divided into five groups. No material was added to the nipple of the Group 1 (control). Group 2 received 0.4 mg/day nanoparticles of iron; Group 3 received 0.4 mg/day ferrous sulfate, and Groups 4 and 5 received double dose of iron nanoparticle and ferrous sulfate, respectively for ten days. Results: Hemoglobin and red blood cell (RBC) in Group 2 were significantly higher than Group 3 (P < 0.05). In addition, hemoglobin and RBC in Group 4 and 5 were significantly higher than Group 3 (P < 0.05). The average level of serum iron in Groups 2 and 4 was remarkably more than the groups received ferrous sulfate with similar doses (P < 0.05). C-reactive protein in Group 3 was more than Group 2 and in Group 5 was more compare to all other groups. Conclusions: Single dose of nanoparticles had more bioavailability compare to ferrous sulfate, but this did not occur for the double dose. Furthermore, both doses of nanoparticles caused lower inflammation than ferrous sulfate.


How to cite this article:
Shafie EH, Keshavarz SA, Kefayati ME, Taheri F, Sarbakhsh P, Vafa MR. The effects of nanoparticles containing iron on blood and inflammatory markers in comparison to ferrous sulfate in anemic rats.Int J Prev Med 2016;7:117-117


How to cite this URL:
Shafie EH, Keshavarz SA, Kefayati ME, Taheri F, Sarbakhsh P, Vafa MR. The effects of nanoparticles containing iron on blood and inflammatory markers in comparison to ferrous sulfate in anemic rats. Int J Prev Med [serial online] 2016 [cited 2020 Dec 3 ];7:117-117
Available from: https://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2016;volume=7;issue=1;spage=117;epage=117;aulast=Shafie;type=0